Global Digital Biomarkers Market 2020-2030 by System Component, Therapeutic Area, Application, Development Status, End User, and Region: Trend Forecast and Growth Opportunity

August 2020 | 199 pages | ID: G2665EDB5863EN
GMD Research

Abstracts

Global digital biomarkers market will reach $22.54 billion by 2030, growing by 36.2% annually over 2020-2030 driven by rising demand for mobile health apps, elevated level of smartphone and wearable technology in healthcare.

Highlighted with 91 tables and 99 figures, this 199-page report “Global Digital Biomarkers Market 2020-2030 by System Component, Therapeutic Area, Application, Development Status, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global digital biomarkers market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global digital biomarkers market in every aspect of the classification from perspectives of System Component, Therapeutic Area, Application, Development Status, End User, and Region.

Based on System Component, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Data Collection Tools

• Digital Platforms
• Mobile Apps
• Desktop-based Software
• Wearables
• Biosensors

Data Integration Systems

Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Cardiovascular Diseases
Neurodegenerative Disorders

• Parkinson’s Disease
• Multiple Sclerosis
• Alzheimer’s Disease

Sleep and Movement Diseases
Psychiatric Disorders
Chronic Pain
Gastrointestinal Diseases
Diabetes
Respiratory Conditions
Other Diseases

Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Wellness
• Disease Diagnosis
• Personalised Medication
• Drug Discovery and Development

Based on Development Status, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Novel Digital Biomarkers
• Original Digital Biomarkers
• Approved Digital Biomarkers

Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Biopharmaceutical Companies & Labs
• Healthcare Providers
• Insurance Payers

Geographically, the following regions together with the listed national/local markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, The Netherlands, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Spain, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, Israel)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by System Component, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global digital biomarkers market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
Actigraph LLC
Akili Interactive Labs
AliveCor Inc
Altoida Inc
Amgen Inc
Bayer AG
Biogen Inc
Cambridge Cognition Plc
Eli Lilly and Company
Evidation Health, Inc.
F. Hoffmann-La Roche Ltd
Fitbit Inc
GlaxoSmithKline Plc
Happify Health
Human API
IXICO Plc
Koninklijke Philips N.V.
Medical Care Corporation
Medopad Ltd
Mindstrong Health
Neurotrack Technology, Inc
Novartis International AG
Pfizer Inc.
Quanterix Corporation
Sanofi S.A.
The Takeda Pharmaceuticals Company Limited
Verily Life Sciences
Winterlight Labs Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY SYSTEM COMPONENT

3.1 Market Overview by System Component
3.2 Data Collection Tools
  3.2.1 Digital Platforms
  3.2.2 Mobile Apps
  3.2.3 Desktop-based Software
  3.2.4 Wearables
  3.2.5 Biosensors
3.3 Data Integration Systems

4 SEGMENTATION OF GLOBAL MARKET BY THERAPEUTIC AREA

4.1 Market Overview by Therapeutic Area
4.2 Cardiovascular Diseases
4.3 Neurodegenerative Disorders
  4.3.1 Parkinson’s Disease
  4.3.2 Multiple Sclerosis
  4.3.3 Alzheimer’s Disease
4.4 Sleep and Movement Diseases
4.5 Psychiatric Disorders
4.6 Chronic Pain
4.7 Gastrointestinal Diseases
4.8 Diabetes
4.9 Respiratory Conditions
4.10 Other Diseases

5 SEGMENTATION OF GLOBAL MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Wellness
5.3 Disease Diagnosis
5.4 Personalised Medication
5.5 Drug Discovery and Development

6 SEGMENTATION OF GLOBAL MARKET BY DEVELOPMENT STATUS

6.1 Market Overview by Development Status
6.2 Novel Digital Biomarkers
6.3 Original Digital Biomarkers
6.4 Approved Digital Biomarkers

7 SEGMENTATION OF GLOBAL MARKET BY END USER

7.1 Market Overview by End User
7.2 Biopharmaceutical Companies & Labs
7.3 Healthcare Providers
7.4 Insurance Payers

8 SEGMENTATION OF GLOBAL MARKET BY REGION

8.1 Geographic Market Overview 2019-2030
8.2 North America Market 2019-2030 by Country
  8.2.1 Overview of North America Market
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 European Market 2019-2030 by Country
  8.3.1 Overview of European Market
  8.3.2 Germany
  8.3.3 UK
  8.3.4 France
  8.3.5 Netherlands
  8.3.6 Italy
  8.3.7 Russia
  8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2019-2030 by Country
  8.4.1 Overview of Asia-Pacific Market
  8.4.2 Japan
  8.4.3 China
  8.4.4 Australia
  8.4.5 India
  8.4.6 South Korea
  8.4.7 Rest of APAC Region
8.5 South America Market 2019-2030 by Country
  8.5.1 Argentina
  8.5.2 Brazil
  8.5.3 Chile
  8.5.4 Rest of South America Market
8.6 MEA Market 2019-2030 by Country
  8.6.1 UAE
  8.6.2 Saudi Arabia
  8.6.3 Israel
  8.6.4 Other National Markets

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Actigraph LLC
Akili Interactive Labs
AliveCor Inc
Altoida Inc
Amgen Inc
Bayer AG
Biogen Inc
Cambridge Cognition Plc
Eli Lilly and Company
Evidation Health, Inc.
F. Hoffmann-La Roche Ltd
Fitbit Inc
GlaxoSmithKline Plc
Happify Health
Human API
IXICO Plc
Koninklijke Philips N.V.
Medical Care Corporation
Medopad Ltd
Mindstrong Health
Neurotrack Technology, Inc
Novartis International AG
Pfizer Inc.
Quanterix Corporation
Sanofi S.A.
The Takeda Pharmaceuticals Company Limited
Verily Life Sciences
Winterlight Labs Inc.

10 INVESTING IN GLOBAL MARKET: RISK ASSESSMENT AND MANAGEMENT

10.1 Risk Evaluation of Global Market
10.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Digital Biomarkers Market, 2019-2030
Table 2. Overview of Traditional and Digital Biomarker Features, Novel Applications, and Published Examples
Table 3. World Smartphone Connections, Average Network Connection Speed for Smartphones and Tablets, 2019-2030
Table 4. World Mobile Data Traffic by Deployment Mode, 2019-2030, EB/year
Table 5. World Mobile Data Traffic by Device, 2019-2030, EB/year
Table 6. Current Challenges of Digital Biomarkers in Medical Settings
Table 7. Main Product Trends and Market Opportunities in Global Digital Biomarkers Market
Table 8. Global Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 9. Global Digital Biomarkers Market: Data Collection Tools by Type, 2019-2030, $ mn
Table 10. Global Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 11. Global Digital Biomarkers Market: Neurodegenerative Disorders by Type, 2019-2030, $ mn
Table 12. Global Digital Biomarkers Market by Application, 2019-2030, $ mn
Table 13. Global Digital Biomarkers Market by Development Status, 2019-2030, $ mn
Table 14. Global Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 15. Global Digital Biomarkers Market by Region, 2019-2030, $ mn
Table 16. Leading National Digital Biomarkers Market, 2019 and 2030, $ mn
Table 17. North America Digital Biomarkers Market by Country, 2019-2030, $ mn
Table 18. U.S. Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 19. U.S. Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 20. U.S. Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 21. Canada Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 22. Canada Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 23. Canada Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 24. Mexico Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 25. Mexico Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 26. Mexico Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 27. Europe Digital Biomarkers Market by Country, 2019-2030, $ mn
Table 28. Germany Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 29. Germany Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 30. Germany Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 31. UK Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 32. UK Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 33. UK Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 34. France Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 35. France Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 36. France Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 37. Netherlands Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 38. Netherlands Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 39. Netherlands Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 40. Italy Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 41. Italy Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 42. Italy Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 43. Russia Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 44. Russia Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 45. Russia Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 46. Digital Biomarkers Market in Rest of Europe by Country, 2019-2030, $ mn
Table 47. APAC Digital Biomarkers Market by Country, 2019-2030, $ mn
Table 48. Japan Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 49. Japan Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 50. Japan Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 51. China Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 52. China Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 53. China Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 54. Australia Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 55. Australia Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 56. Australia Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 57. India Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 58. India Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 59. India Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 60. South Korea Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 61. South Korea Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 62. South Korea Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 63. Digital Biomarkers Market in Rest of APAC by Country, 2019-2030, $ mn
Table 64. South America Digital Biomarkers Market by Country, 2019-2030, $ mn
Table 65. Argentina Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 66. Argentina Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 67. Argentina Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 68. Brazil Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 69. Brazil Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 70. Brazil Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 71. Chile Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 72. Chile Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 73. Chile Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 74. MEA Digital Biomarkers Market by Country, 2019-2030, $ mn
Table 75. UAE Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 76. UAE Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 77. UAE Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 78. Saudi Arabia Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 79. Saudi Arabia Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 80. Saudi Arabia Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 81. Israel Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 82. Israel Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 83. Israel Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 84. Breakdown of Global Market by Key Vendor, 2019, %
Table 85. Actigraph LLC: Company Snapshot
Table 86. Actigraph LLC: Business Segmentation
Table 87. Actigraph LLC: Product Portfolio
Table 88. Actigraph LLC: Revenue, 2016-2018, $ mn
Table 89. Actigraph LLC: Recent Developments
Table 90. Risk Evaluation for Investing in Global Market, 2019-2030
Table 91. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Global Digital Biomarkers Market, 2019-2030, $ mn
Figure 6. Category and Relationship of Traditional Biomarkers and Digital Biomarkers
Figure 7. Benefits and Challenges of Digital Biomarkers
Figure 8. Global Biomarkers Market, 2019-2030, $ mn
Figure 9. Share of Digital Biomarkers in Total Biomarkers Market, 2019-2030
Figure 10. Impact of COVID-19 on Business
Figure 11. Primary Drivers and Impact Factors of Global Digital Biomarkers Market
Figure 12. World 5G Traffic, 2019-2030, EB/year
Figure 13. Primary Restraints and Impact Factors of Global Digital Biomarkers Market
Figure 14. Data Security Risk in Various User Groups of Digital Biomarkers
Figure 15. Pathway to Regulatory Approval of Digital Biomarkers
Figure 16. Investment Opportunity Analysis
Figure 17. Porter’s Fiver Forces Analysis of Global Digital Biomarkers Market
Figure 18. Breakdown of Global Digital Biomarkers Market by System Component, 2019-2030, % of Revenue
Figure 19. Global Addressable Market Cap in 2020-2030 by System Component, Value ($ mn) and Share (%)
Figure 20. Global Digital Biomarkers Market: Data Collection Tools, 2019-2030, $ mn
Figure 21. Global Digital Biomarkers Market: Digital Platforms, 2019-2030, $ mn
Figure 22. Global Digital Biomarkers Market: Mobile Apps, 2019-2030, $ mn
Figure 23. Global Digital Biomarkers Market: Desktop-based Software, 2019-2030, $ mn
Figure 24. Global Digital Biomarkers Market: Wearables, 2019-2030, $ mn
Figure 25. Global Digital Biomarkers Market: Biosensors, 2019-2030, $ mn
Figure 26. Global Digital Biomarkers Market: Data Integration Systems, 2019-2030, $ mn
Figure 27. Breakdown of Global Digital Biomarkers Market by Therapeutic Area, 2019-2030, % of Sales Revenue
Figure 28. Global Addressable Market Cap in 2020-2030 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 29. Global Digital Biomarkers Market: Cardiovascular Diseases, 2019-2030, $ mn
Figure 30. Global Digital Biomarkers Market: Neurodegenerative Disorders, 2019-2030, $ mn
Figure 31. Global Digital Biomarkers Market: Parkinson’s Disease, 2019-2030, $ mn
Figure 32. Global Digital Biomarkers Market: Multiple Sclerosis, 2019-2030, $ mn
Figure 33. Global Digital Biomarkers Market: Alzheimer’s Disease, 2019-2030, $ mn
Figure 34. Global Digital Biomarkers Market: Sleep and Movement Diseases, 2019-2030, $ mn
Figure 35. Global Digital Biomarkers Market: Psychiatric Disorders, 2019-2030, $ mn
Figure 36. Global Digital Biomarkers Market: Chronic Pain, 2019-2030, $ mn
Figure 37. Global Digital Biomarkers Market: Gastrointestinal Diseases, 2019-2030, $ mn
Figure 38. Global Digital Biomarkers Market: Diabetes, 2019-2030, $ mn
Figure 39. Global Digital Biomarkers Market: Respiratory Conditions, 2019-2030, $ mn
Figure 40. Global Digital Biomarkers Market: Other Diseases, 2019-2030, $ mn
Figure 41. Breakdown of Global Digital Biomarkers Market by Application, 2019-2030, % of Sales Revenue
Figure 42. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 43. Global Digital Biomarkers Market: Wellness, 2019-2030, $ mn
Figure 44. Global Digital Biomarkers Market: Disease Diagnosis, 2019-2030, $ mn
Figure 45. Global Digital Biomarkers Market: Personalised Medication, 2019-2030, $ mn
Figure 46. Global Digital Biomarkers Market: Drug Discovery and Development, 2019-2030, $ mn
Figure 47. Classification of Digital Biomarkers by Development Status
Figure 48. Breakdown of Global Digital Biomarkers Market by Development Status, 2019-2030, % of Revenue
Figure 49. Global Addressable Market Cap in 2020-2030 by Development Status, Value ($ mn) and Share (%)
Figure 50. Global Digital Biomarkers Market: Novel Digital Biomarkers, 2019-2030, $ mn
Figure 51. Global Digital Biomarkers Market: Original Digital Biomarkers, 2019-2030, $ mn
Figure 52. Global Digital Biomarkers Market: Approved Digital Biomarkers, 2019-2030, $ mn
Figure 53. Breakdown of Global Digital Biomarkers Market by End User, 2019-2030, % of Revenue
Figure 54. Global Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)
Figure 55. Global Digital Biomarkers Market: Biopharmaceutical Companies & Labs, 2019-2030, $ mn
Figure 56. Global Digital Biomarkers Market: Healthcare Providers, 2019-2030, $ mn
Figure 57. Global Digital Biomarkers Market: Insurance Payers, 2019-2030, $ mn
Figure 58. Global Market Snapshot by Region
Figure 59. Geographic Spread of Worldwide Digital Biomarkers Market, 2019-2030, % of Sales Revenue
Figure 60. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%)
Figure 61. North American Digital Biomarkers Market, 2019-2030, $ mn
Figure 62. Breakdown of North America Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue
Figure 63. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 64. U.S. Digital Biomarkers Market, 2019-2030, $ mn
Figure 65. Canada Digital Biomarkers Market, 2019-2030, $ mn
Figure 66. Digital Biomarkers Market in Mexico, 2015-2030, $ mn
Figure 67. European Digital Biomarkers Market, 2019-2030, $ mn
Figure 68. Breakdown of European Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue
Figure 69. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 70. Digital Biomarkers Market in Germany, 2019-2030, $ mn
Figure 71. Digital Biomarkers Market in UK, 2019-2030, $ mn
Figure 72. Digital Biomarkers Market in France, 2019-2030, $ mn
Figure 73. Digital Biomarkers Market in Netherlands, 2019-2030, $ mn
Figure 74. Digital Biomarkers Market in Italy, 2019-2030, $ mn
Figure 75. Digital Biomarkers Market in Russia, 2019-2030, $ mn
Figure 76. Digital Biomarkers Market in Rest of Europe, 2019-2030, $ mn
Figure 77. Asia-Pacific Digital Biomarkers Market, 2019-2030, $ mn
Figure 78. Breakdown of APAC Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue
Figure 79. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 80. Digital Biomarkers Market in Japan, 2019-2030, $ mn
Figure 81. Digital Biomarkers Market in China, 2019-2030, $ mn
Figure 82. Digital Biomarkers Market in Australia, 2019-2030, $ mn
Figure 83. Digital Biomarkers Market in India, 2019-2030, $ mn
Figure 84. Digital Biomarkers Market in South Korea, 2019-2030, $ mn
Figure 85. Digital Biomarkers Market in Rest of APAC, 2019-2030, $ mn
Figure 86. South America Digital Biomarkers Market, 2019-2030, $ mn
Figure 87. Breakdown of South America Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue
Figure 88. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 89. Digital Biomarkers Market in Argentina, 2019-2030, $ mn
Figure 90. Digital Biomarkers Market in Brazil, 2019-2030, $ mn
Figure 91. Digital Biomarkers Market in Chile, 2019-2030, $ mn
Figure 92. Digital Biomarkers Market in Rest of South America, 2019-2030, $ mn
Figure 93. Digital Biomarkers Market in Middle East and Africa (MEA), 2019-2030, $ mn
Figure 94. Breakdown of MEA Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue
Figure 95. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 96. Digital Biomarkers Market in UAE, 2019-2030, $ mn
Figure 97. Digital Biomarkers Market in Saudi Arabia, 2019-2030, $ mn
Figure 98. Digital Biomarkers Market in Israel, 2019-2030, $ mn
Figure 99. Growth Stage of Global Digital Biomarkers Industry over the Forecast Period


COMPANIES MENTIONED

Actigraph LLC
Akili Interactive Labs
AliveCor Inc
Altoida Inc
Amgen Inc
Bayer AG
Biogen Inc
Cambridge Cognition Plc
Eli Lilly and Company
Evidation Health, Inc.
F. Hoffmann-La Roche Ltd
Fitbit Inc
GlaxoSmithKline Plc
Happify Health
Human API
IXICO Plc
Koninklijke Philips N.V.
Medical Care Corporation
Medopad Ltd
Mindstrong Health
Neurotrack Technology, Inc
Novartis International AG
Pfizer Inc.
Quanterix Corporation
Sanofi S.A.
The Takeda Pharmaceuticals Company Limited
Verily Life Sciences
Winterlight Labs Inc.